IRIS
DANESE, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.449
AS - Asia 16.338
EU - Europa 6.001
SA - Sud America 3.210
AF - Africa 875
Continente sconosciuto - Info sul continente non disponibili 770
OC - Oceania 58
AN - Antartide 1
Totale 62.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.637
SG - Singapore 10.351
BR - Brasile 2.636
CN - Cina 2.450
VN - Vietnam 1.563
IT - Italia 1.335
FI - Finlandia 1.022
IE - Irlanda 721
NG - Nigeria 594
DE - Germania 569
FR - Francia 490
CA - Canada 466
GB - Regno Unito 450
HK - Hong Kong 443
IN - India 268
NL - Olanda 264
SE - Svezia 210
AR - Argentina 200
RU - Federazione Russa 199
BD - Bangladesh 176
TR - Turchia 175
MX - Messico 134
IQ - Iraq 119
IL - Israele 116
ES - Italia 112
BE - Belgio 101
PL - Polonia 95
UA - Ucraina 93
EC - Ecuador 86
JP - Giappone 86
ZA - Sudafrica 82
ID - Indonesia 76
CO - Colombia 71
CL - Cile 67
RO - Romania 59
VE - Venezuela 56
PK - Pakistan 55
AU - Australia 48
SA - Arabia Saudita 48
PH - Filippine 46
A2 - ???statistics.table.value.countryCode.A2??? 41
PY - Paraguay 39
EG - Egitto 38
UZ - Uzbekistan 38
CR - Costa Rica 37
CZ - Repubblica Ceca 36
MA - Marocco 36
MY - Malesia 35
GR - Grecia 34
JM - Giamaica 31
JO - Giordania 31
IR - Iran 28
AE - Emirati Arabi Uniti 27
HN - Honduras 27
LT - Lituania 27
KR - Corea 26
NP - Nepal 25
CH - Svizzera 22
KE - Kenya 22
SC - Seychelles 22
TN - Tunisia 22
TT - Trinidad e Tobago 22
AT - Austria 21
DZ - Algeria 21
PE - Perù 21
KZ - Kazakistan 20
UY - Uruguay 20
AL - Albania 18
AZ - Azerbaigian 18
NO - Norvegia 18
GT - Guatemala 17
PT - Portogallo 16
MD - Moldavia 15
LB - Libano 14
DO - Repubblica Dominicana 13
SV - El Salvador 13
DK - Danimarca 12
NI - Nicaragua 12
PR - Porto Rico 12
EE - Estonia 11
ET - Etiopia 11
SY - Repubblica araba siriana 11
TH - Thailandia 11
KG - Kirghizistan 10
BO - Bolivia 9
BY - Bielorussia 9
OM - Oman 9
CY - Cipro 8
PA - Panama 8
SN - Senegal 8
CW - ???statistics.table.value.countryCode.CW??? 7
HU - Ungheria 7
PS - Palestinian Territory 7
AM - Armenia 6
NZ - Nuova Zelanda 6
TW - Taiwan 6
BB - Barbados 5
BN - Brunei Darussalam 5
MK - Macedonia 5
QA - Qatar 5
Totale 61.880
Salva come PNG Salva come JPEG
Città #
Singapore 4.913
Chandler 4.187
Wilmington 4.040
Ashburn 1.847
San Mateo 1.632
The Dalles 1.599
San Jose 1.364
Ann Arbor 1.255
Dallas 1.243
Shanghai 1.135
Helsinki 1.018
Council Bluffs 851
Princeton 747
Lawrence 716
Dublin 713
Leawood 702
Boardman 699
New York 635
Benin City 588
Milan 547
Ho Chi Minh City 523
Beijing 512
Santa Clara 430
Hong Kong 408
Paris 405
Hanoi 404
Woodbridge 383
Fairfield 371
Los Angeles 332
Phoenix 249
Amsterdam 241
Rome 241
Toronto 206
São Paulo 205
London 194
Seattle 184
Columbus 182
North Bergen 158
Buffalo 145
Norwalk 114
San Diego 113
Chicago 104
Orem 96
Rio de Janeiro 94
Kocaeli 92
Brussels 90
Houston 88
Atlanta 86
Brooklyn 85
Belo Horizonte 72
Da Nang 64
Warsaw 60
Brasília 59
Charlotte 59
Montreal 59
Haiphong 58
Tokyo 58
Falkenstein 56
Miami 54
Las Vegas 51
Naples 51
Chennai 48
Munich 48
Campinas 47
Philadelphia 47
Redwood City 47
San Francisco 43
Mexico City 42
Queens 42
Figino 41
Pune 41
Frankfurt am Main 40
Johannesburg 40
Falls Church 38
Baghdad 37
Boston 36
Monmouth Junction 36
Moscow 36
Curitiba 34
Abbiategrasso 33
Clearwater 33
Cleveland 33
Porto Alegre 32
Tashkent 32
Turin 31
Cambridge 30
Des Moines 30
Manchester 30
Denver 29
Amman 28
Guayaquil 28
The Bronx 28
Birmingham 27
San José 27
Biên Hòa 26
Brno 26
Mumbai 26
Ottawa 26
Dhaka 25
Quito 25
Totale 39.215
Salva come PNG Salva come JPEG
Nome #
Biological agents for ulcerative colitis : Hypes and hopes 322
Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion 288
Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial 222
Crohn's disease 180
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 176
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 174
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 160
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 158
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 157
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 155
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 155
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 154
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 149
Endoscopic flexible treatment of Zenker's diverticulum: a modification of the needle-knife technique 148
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 148
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis 144
Review article: optimal preparation for surgery in Crohn's disease 143
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 143
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 142
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease 141
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 140
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease 140
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 138
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 138
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial 138
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 137
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 135
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 135
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 134
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 132
Ulcerative Colitis 131
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 131
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 131
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 130
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 129
Risk of postoperative recurrence and postoperative management of Crohn's disease 129
Intestinal microbiota in inflammatory bowel disease: Friend of foe? 129
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. 129
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 128
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease 128
Laparoscopic Surgery for Recurrent Crohn's Disease 127
Methylene blue MMX (R) tablets for chromoendoscopy. Safety tolerability and bioavailability in healthy volunteers 127
Perception of reproductive health in women with inflammatory bowel disease 126
Colitis-associated cancer: the dark side of inflammatory bowel disease 126
Imaging Modalities for Perianal Crohn's Disease 125
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 124
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis 124
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 123
Second-Generation Corticosteroids for the Treatment of Crohn's Disease and Ulcerative Colitis: More Effective and Less Side Effects? 122
Biological therapies for inflammatory bowel disease: Research drives clinics 121
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study 121
Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome. 121
Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease 121
Inflammatory bowel disease: the role of environmental factors 120
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 120
Adalimumab in active ulcerative colitis: A "real-life" observational study 120
A Multidisciplinary Approach to Rectal Cancer Treatment in Ulcerative Colitis Results in High Rate of Restorative Minimally Invasive Surgery 119
Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice 119
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 118
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD 118
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 117
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 117
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 117
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 116
Development and validation of the Nancy histological index for UC 116
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2 116
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 116
Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation 115
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 115
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 115
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? 114
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients 114
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment 114
Management of IBD during the COVID-19 outbreak: resetting clinical priorities 114
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 113
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 113
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. 112
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer 112
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis 112
A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities 112
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 111
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 111
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 110
Evolving strategies and goals of treatment in ulcerative colitis 110
Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations 110
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX® FOR MILD-TO-MODERATE ULCERATIVE COLITIS 110
IBD Of mice and men-shedding new light on IL-13 activity in IBD 109
Surgical rates in the era of biological therapy: up, down or unchanged? 109
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study 109
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 109
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease 109
Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations 108
Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease 108
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 108
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 108
Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications 108
Regulation of leukocyte recruitment by the long pentraxin PTX3. 108
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? 107
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis 107
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells (LPT) contributes to mucosal inflammation 106
Totale 13.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 421.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 421.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.045 0 0 0 0 39 48 127 554 391 708 943 235
2022/202310.508 1.606 443 1.059 1.207 896 952 32 939 1.827 865 553 129
2023/20245.131 439 529 1.152 220 179 613 231 276 98 89 425 880
2024/20257.671 223 196 74 214 228 939 357 975 984 1.836 811 834
2025/202619.599 2.911 1.131 1.322 1.818 576 645 5.910 1.045 1.063 1.153 635 1.390
2026/20277.964 1.606 1.739 3.001 1.359 259 0 0 0 0 0 0 0
Totale 62.702